erus BioSciences(CHRS) - 2025 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 27-3615821 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 333 Twin Dolphin Drive, Suite 600 Redwood City, California (Address of Principal Executive Office) 94065 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 1 ...